Pharmacists Take Charge During an In-Flight Medical Emergency
Drug Topics
DECEMBER 9, 2022
A group of pharmacists rose to the occasion to help a man having a medical emergency aboard a recent United flight bound for Newark, New Jersey.
Fri.Dec 09, 2022
689 
ICYMI: PhRMA COO Lori Reilly speaks about the health care agenda for the next Congress
PhRMA
DECEMBER 9, 2022
With a divided Congress, bipartisan action will be necessary to move the needle on health care policy. On December 7, 2022, PhRMA sponsored the Axios event, “ The Post-Midterm Health Care Agenda ,” where I participated in a View from the Top segment with Nicholas Johnston, publisher of Axios. We discussed PhRMA’s focus on passing the PASTEUR Act in the last few weeks of 2022, and laid out PhRMA’s priorities heading into 2023 that will support and protect patients.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Best of the Best: Delaney Santon, CPHT, on How Pharmacy Techs Help Patients
Drug Topics
DECEMBER 9, 2022
Winner of SingleCare's Best of the Best: Best Pharmacy Technician, Santon joined Drug Topics® to discuss what pharmacy technicians can do for patients and why it's so important to her for every patient to afford their medication.
Dr. Sy Pretorius, Eversana’s new COO, is flipping the script on his career
PharmaVoice
DECEMBER 9, 2022
With a long history in the clinical space, Pretorius is now applying those deep insights to the commercial side of the business.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Legislation Must Control Drug Prices and Support Innovations like Biosimilars
Drug Topics
DECEMBER 9, 2022
The U.S. biosimilar landscape is changing, and legislation may be the key to controlling drug prices and advancing the market.
With FDA filing on the horizon, Karuna appoints new CEO
PharmaVoice
DECEMBER 9, 2022
Allergan alum Bill Meury will take the helm as current CEO Steve Paul transitions to lead R&D.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Opinion: Artificial intelligence: crossing the border between health care and tech
STAT
DECEMBER 9, 2022
There’s been significant investment in companies creating artificial intelligence (AI) applications for health and health care over the last decade. But while there have been successes, notably in the area of medical imaging, the industry is known more for not yet living up to its potential — think IBM Watson. The slow pace of AI adoption in health care stems from the fact that health AI sits on the border between two large industries, health care and tech.
Case Study: Endobronchial Foreign Objects Can Present as Cough, Chest Pain
Pharmacy Times
DECEMBER 9, 2022
Clinicians should consider potential aspiration of illicit drug packets that were swallowed or inserted into the body.
Mark Cuban's drug company targets self-insured employer market
Fierce Healthcare
DECEMBER 9, 2022
Mark Cuban's drug company targets self-insured employer market. hlandi. Fri, 12/09/2022 - 13:51.
Updated USPSTF Guidelines Show Benefits of Screening for Obstructive Sleep Apnea Do Not Outweigh Harms
Pharmacy Times
DECEMBER 9, 2022
The decision is updated from a 2017 recommendation to screen people for obstructive sleep apnea, which can lead to daytime sleepiness and other adverse outcomes.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
IHI Forum: Don Berwick calls out greed, rallies industry to protest monetization of healthcare
Fierce Healthcare
DECEMBER 9, 2022
IHI Forum: Don Berwick calls out greed, rallies industry to protest monetization of healthcare. agliadkovskaya. Fri, 12/09/2022 - 18:09.
Research Supports Efficacy, Safety of Palivizumab Preventing Lower Respiratory Tract Infections by RSV
Pharmacy Times
DECEMBER 9, 2022
Palivizumab is a humanized monoclonal antibody approved by the FDA to prevent serious lower respiratory tract infection caused by respiratory syncytial virus in infants and young children.
FDA OKs bivalent COVID boosters for kids as young 6 months
Fierce Healthcare
DECEMBER 9, 2022
FDA OKs bivalent COVID boosters for kids as young 6 months. fdiamond. Fri, 12/09/2022 - 07:49.
Zavegepant Nasal Spray Shows Promise in Acute Treatment of Migraine
Pharmacy Times
DECEMBER 9, 2022
Zavegepant could become the first intranasal drug that targets CGRP in migraine sufferers to gain FDA approval.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT+: 5 ways health tech companies can make their products more equitable
STAT
DECEMBER 9, 2022
Disparities along racial and socioeconomic lines have long persisted in health care. But it’s only somewhat recently that the health care industry’s often glitzy gatherings have started grappling with health equity, as the pandemic both widened health inequities and also demonstrated the potential of technology to tackle them. Companies selling sleek and convenient digital health services like virtual doctors’ visits or apps to manage diabetes often struggle to get them into
Treatment With Atrasentan Improves Albuminuria in Patients With Chronic Kidney Disease, Diabetes
Pharmacy Times
DECEMBER 9, 2022
Atrasentan has been found to lower albuminuria, which correlates with reductions in low-density lipoprotein cholesterol and triglycerides.
Blue Shield of California partners with DispatchHealth for in-home care
Fierce Healthcare
DECEMBER 9, 2022
Blue Shield of California partners with DispatchHealth for in-home care. pminemyer. Fri, 12/09/2022 - 13:49.
Study Confirms Benefit of Rivaroxaban for Secondary Prevention of Venous Thromboembolism in Patients With Cancer
Pharmacy Times
DECEMBER 9, 2022
At 3 and 6 months, rivaroxaban was found to be as effective and safe as apixaban in the composite outcome of recurrent venous thromboembolism or bleeding-related hospitalization.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Many Americans view the economy as a major healthcare concern: Oscar Health survey
Fierce Healthcare
DECEMBER 9, 2022
Many Americans view the economy as a major healthcare concern: Oscar Health survey. pminemyer. Fri, 12/09/2022 - 15:58.
TDM1, Radiation Considered Safe for Patients with Early-Stage HER2-Positive Breast Cancer
Pharmacy Times
DECEMBER 9, 2022
Expert sits with Pharmacy Times to share the promising results of a study that evaluated the safety of a new antibody drug conjugate with radiation therapy.
Medscape physician survey reveals attitudes on anti-vaxxers, expensive treatment plans, other ethical dilemmas
Fierce Healthcare
DECEMBER 9, 2022
Medscape physician survey reveals attitudes on anti-vaxxers, expensive treatment plans, other ethical dilemmas. agliadkovskaya. Fri, 12/09/2022 - 12:40.
AZ writes the 'next chapter' in Enhertu's saga with head-to-head win versus Roche's Kadcyla
Fierce Pharma
DECEMBER 9, 2022
AZ writes the 'next chapter' in Enhertu's saga with head-to-head win versus Roche's Kadcyla. fkansteiner. Fri, 12/09/2022 - 09:22.
STAT+: Up and down the ladder: The latest comings and goings
STAT
DECEMBER 9, 2022
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which we highlight a different person each week.
ASH: Bristol Myers bolsters Breyanzi's case in earlier lymphoma amid clash with Gilead
Fierce Pharma
DECEMBER 9, 2022
ASH: Bristol Myers bolsters Breyanzi's case in earlier lymphoma amid clash with Gilead. aliu. Fri, 12/09/2022 - 09:15.
Ballerina, firefighter, hygienist? Why dentistry needs to start its pipeline with young kids
STAT
DECEMBER 9, 2022
Dentistry has a diversity problem, and medical and dental experts say the best way to fix it is to start the pipeline early in Black and brown communities. “We can’t wait until someone graduates from undergrad to try to recruit an African American or Hispanic dentist,” Gillian Barclay, vice president of global public health at Colgate-Palmolive, said at the Milken Institute Future of Health Summit on Wednesday.
What is Stiff-Person Syndrome?
Board Vitals - Pharmacist
DECEMBER 9, 2022
World-renowned singer, Celine Dion, recently announced on her Instagram the cancellation of tour dates due to her diagnosis of Stiff-Person Syndrome. What is Stiff-Person Syndrome (SPS), and how is it diagnosed and treated? . What is SPS? Stiff-Person Syndrome (SPS) is an extremely rare disease , affecting only one out of every million people. In fact, many neurologists will go their entire careers and only see one or two instances of the condition.
STAT+: Why a tone-deaf Regeneron executive deserved to be booed over Alzheimer’s drug remarks
STAT
DECEMBER 9, 2022
File this under “What was he thinking?” The otherwise staid Milken Institute summit on health care grew unexpectedly heated on Thursday when George Yancopoulos, the Regeneron Pharmaceuticals president and chief scientific officer, drew boos from the crowd as he became cantankerous and talked over the panel moderator, who had expressed concern about access to high-priced Alzheimer’s medicines.
As Twitter rolls back its ban on COVID misinformation, some health experts worry about threat to public health
Fierce Healthcare
DECEMBER 9, 2022
As Twitter rolls back its ban on COVID misinformation, some health experts worry about threat to public health. aburky. Fri, 12/09/2022 - 17:35.
SABCS: New ADC from AZ and Daiichi shows promise in breast cancer
pharmaphorum
DECEMBER 9, 2022
AstraZeneca and Daiichi Sankyo’s antibody-drug conjugate (ADC) Enhertu is already making waves in breast cancer, and clinical results presented at the San Antonio Breast Cancer Symposium (SABCS) suggest they may see success with a second. The two partners say new data from the phase 1 TROPION-PanTumor01 of TROP2-targeting datopotamab deruxtecan showed “encouraging and durable efficacy” when used to treat patients with hormone receptor (HR)-positive, HER2-low, or HER2-negative metastatic breast c
The Brazilian pharma market: Key information and what may change
Pharmaceutical Technology
DECEMBER 9, 2022
Brazil is the largest country in Latin America, with a population of over 212 million, and consequently has the biggest pharmaceutical market in the region. This size alone brings significant benefits to its citizens, with Brazil having a publicly funded and government-run healthcare system offering free and universal access to healthcare for the entire population.
Oligonucleotide synthesis market to reach $16.7 billion by 2027
European Pharmaceutical Review
DECEMBER 9, 2022
According to a new market report by ResearchAndMarkets, the global oligonucleotide synthesis market is projected to reach $16.7 billion by 2027 during the forecast period, due to the rise in ongoing clinical trials for oligonucleotide-based therapies in key therapeutic sectors such as oncology. The research projected a compound annual growth rate (CAGR) of 16.8 percent from $7.7 billion in 2022.
The best SingleCare reviews of 2022
The Checkup by Singlecare
DECEMBER 9, 2022
It’s almost time to ring in a new year, and for many, that means setting resolutions to live healthier. Whether your goal is to lose weight, build muscle , or manage conditions like insulin resistance or Type 2 diabetes , SingleCare’s blog, The Checkup , has plenty of health and wellness articles to ensure you have a happy and healthy 2023. We’re also here to help you save big on your prescription costs year-round.
Autolus announces primary endpoint met in FELIX trial, prices public offering
pharmaphorum
DECEMBER 9, 2022
Autolus Therapeutic Plc. (Nasdaq: AUTL), a clinical-stage biopharma and a portfolio company of Syncona Ltd., has announced that the pivotal phase 2 FELIX clinical trial of obecabtagene autoleucel (obe-cel) in relapsed/refractory (r/r) adult Acute Lymphoblastic Leukaemia (ALL) patients has met its primary endpoint of overall remission rate (ORR) at interim analysis.
Let's personalize your content